Image

A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer

Comparing treatments for advanced prostate cancer in a clinical trial.

Recruiting
18 years and older
Male
Phase 3
  • Simplified description (AI rewritten)
  • Technical description (Original)
Study Overview: This study is for men with a type of prostate cancer that has spread and resists treatment with hormones. It's testing a new drug, BMS-986365, against standard treatments chosen by the doctor, which include drugs like Docetaxel, Prednisone, Abiraterone, and Enzalutamide. The main goal is to see which treatment helps patients live longer without their cancer getting worse, as shown on scans (called radiographic progression-free survival or rPFS). Key Points:
  • The study has two parts, and participants will be randomly assigned to different treatment groups.
  • Eligible participants will have previously been treated with certain hormone therapies.
  • Participants cannot have certain conditions, like heart problems or cancer that has spread to the brain or liver.
Participation Requirements: Participants must have prostate cancer with evidence of it spreading, but no brain or liver involvement. They should have tried specific hormone treatments before joining and be in good heart health.
Print
Study details
    Metastatic Castration-resistant Prostate Cancer

NCT06764485

Celgene

21 June 2025

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.